However, different from fasting hyperglycemia, postprandial hyperglycemia is not well controlled with basal insulin therapy and may be the limiting factor for achieving optimal glycemic control for many T2DM patients [3, 4]. This evidence concerns the gene INS and Hyperglycemia.